The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Moderate homocysteinemia--a possible risk factor for arteriosclerotic cerebrovascular disease.
Open accessAbstract
Highly elevated concentrations of homocysteine measured as homocysteine or cysteine-homocysteine mixed disulfide (MDS) are found in plasma and urine in subjects with inherited abnormalities of the methionine metabolism. These subjects have a high incidence of arteriosclerotic vascular complications during childhood. Homocysteine causes endothelial cell injury and cell detachment that initiates the development of arteriosclerosis. The present study demonstrates a significantly elevated mean plasma MDS concentration in 19 patients with arteriosclerotic cerebrovascular disease compared to 17 controls. Our findings suggest that moderate homocysteinemia might be a risk factor for arteriosclerotic cerebrovascular disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Metabolic Basis of Inherited Disease
Solomon, L. M. (1979) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12541649 · Cited by 2,070
Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis.
Ks, M. (1969) · PubMed Central · Cited by 1,803
Harker, L. A., Ross, R., Slichter, S. J., & Scott, C. R. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108520 · Cited by 933
Homocystinemia: Vascular Injury and Arterial Thrombosis
Harker, L. A., Slichter, S. J., Scott, C. R., & Ross, R. (1974) · New England Journal of Medicine · doi:10.1056/nejm197409122911101 · Cited by 662
The pathogenesis of coronary artery disease. A possible role for methionine metabolism.
Wilcken, D. E., & Wilcken, B. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108350 · Cited by 529
Homocysteine-induced endothelial cell injury in vitro: A model for the study of vascular injury
Wall, R. T., Harlan, J. M., Harker, L. A., & Striker, G. E. (1980) · Thrombosis Research · doi:10.1016/0049-3848(80)90175-9 · Cited by 483
Homocysteine theory of arteriosclerosis
McCully, K. S., & Wilson, R. B. (1975) · Atherosclerosis · doi:10.1016/0021-9150(75)90004-0 · Cited by 333
THE DIAGNOSIS OF THE MAJOR AND MINOR SYNDROMES OF BASILAR INSUFFICIENCY
WILLIAMS, D., & WILSON, T. G. (1962) · Brain · doi:10.1093/brain/85.4.741 · Cited by 209
DIFFERENTIAL DIAGNOSIS BETWEEN CEREBRAL HEMORRHAGE AND CEREBRAL THROMBOSIS
Aring, C. D. (1935) · Archives of Internal Medicine · doi:10.1001/archinte.1935.00170010023002 · Cited by 183
Lobar cerebral hemorrhages: Acute clinical syndromes in 26 cases
Ropper, A. H., & Davis, K. R. (1980) · Annals of Neurology · doi:10.1002/ana.410080203 · Cited by 182
Cited by
Boushey, C. J. (1995) · JAMA · doi:10.1001/jama.1995.03530130055028 · Cited by 3,584
Homocysteine and Cardiovascular Disease
Refsum, H., Ueland, P. M., Nygård, O., & Vollset, S. E. (1998) · Annual Review of Medicine · doi:10.1146/annurev.med.49.1.31 · Cited by 2,180
Hyperhomocysteinemia: An Independent Risk Factor for Vascular Disease
Clarke, R., Daly, L., Robinson, K., Naughten, E., Cahalane, S., Fowler, B., & Graham, I. (1991) · New England Journal of Medicine · doi:10.1056/nejm199104253241701 · Cited by 2,161
Homocysteine and Risk of Ischemic Heart Disease and Stroke: A Meta-analysis
Homocysteine Studies Collaboration (2002) · JAMA · doi:10.1001/jama.288.16.2015 · Cited by 2,059
Toole, J. F., Malinow, M. R., Chambless, L. E., Spence, J. D., Pettigrew, L. C., Howard, V. J., Sides, E. G., Wang, C.-H., & Stampfer, M. (2004) · JAMA · doi:10.1001/jama.291.5.565 · Cited by 1,391
Total homocysteine in plasma or serum: methods and clinical applications
Ueland, P. M., Refsum, H., Stabler, S. P., Malinow, M. R., Andersson, A., & Allen, R. H. (1993) · Clinical Chemistry · doi:10.1093/clinchem/39.9.1764 · Cited by 981
Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine.
Starkebaum, G., & Harlan, J. M. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112442 · Cited by 822
Hyperhomocyst(e)inemia as a Risk Factor for Occlusive Vascular Disease
Kang, S. S., Wong, P. W. K., & Malinow, M. R. (1992) · Annual Review of Nutrition · doi:10.1146/annurev.nu.12.070192.001431 · Cited by 762
Heterozygosity for Homocystinuria in Premature Peripheral and Cerebral Occlusive Arterial Disease
Boers, G. H. J., Smals, A. G. H., Trijbels, F. J. M., Fowler, B., Bakkeren, J. A. J. M., Schoonderwaldt, H. C., Kleijer, W. J., & Kloppenborg, P. W. C. (1985) · New England Journal of Medicine · doi:10.1056/nejm198509193131201 · Cited by 732
Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum
Ubbink, J. B., Hayward Vermaak, W. J., & Bissbort, S. (1991) · Journal of Chromatography B: Biomedical Sciences and Applications · doi:10.1016/0378-4347(91)80407-4 · Cited by 678
Homocyst(e)ine Decreases Bioavailable Nitric Oxide by a Mechanism Involving Glutathione Peroxidase
Upchurch, G. R., Welch, G. N., Fabian, A. J., Freedman, J. E., Johnson, J. L., Keaney, J. F., & Loscalzo, J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.27.17012 · Cited by 668
Brattström, L., Wilcken, D. E. L., Öhrvik, J., & Brudin, L. (1998) · Circulation · doi:10.1161/01.cir.98.23.2520 · Cited by 659
Self-citationSelhub, J., & Miller, J. (1992) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/55.1.131 · Cited by 550
Homocysteine and coronary atherosclerosis
Mayer, E. L., Jacobsen, D. W., & Robinson, K. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00508-0 · Cited by 519
The Gasotransmitter Role of Hydrogen Sulfide
Wang, R. (2003) · Antioxidants & Redox Signaling · doi:10.1089/152308603768295249 · Cited by 516
Hyperhomocyst(e)inemia Is a Risk Factor for Arterial Endothelial Dysfunction in Humans
Woo, K. S., Chook, P., Lolin, Y. I., Cheung, A. S. P., Chan, L. T., Sun, Y. Y., Sanderson, J. E., Metreweli, C., & Celermajer, D. S. (1997) · Circulation · doi:10.1161/01.cir.96.8.2542 · Cited by 486
Stabler, S. P., Marcell, P. D., Podell, E. R., Allen, R. H., Savage, D. G., & Lindenbaum, J. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113343 · Cited by 478
Vitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysteinemia
Ubbink, J., Vermaak, W., van der Merwe, A., & Becker, P. (1993) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/57.1.47 · Cited by 461
Heinecke, J. W., Rosen, H., Suzuki, L. A., & Chait, A. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61082-8 · Cited by 460
Homocysteine and Thrombotic Disease
D'Angelo, A., & Selhub, J. (1997) · Blood · doi:10.1182/blood.v90.1.1 · Cited by 439
Homocysteinemia due to folate deficiency
Kang, S.-S., Wong, P. W. K., & Norusis, M. (1987) · Metabolism · doi:10.1016/0026-0495(87)90043-6 · Cited by 421
Brattström, L., Israelsson, B., Norrving, B., Bergqvist, D., Thörne, J., Hultberg, B., & Hamfelt, A. (1990) · Atherosclerosis · doi:10.1016/0021-9150(90)90058-q · Cited by 389
Self-citationA prospective study of plasma homocyst(e)ine and risk of ischemic stroke.
Verhoef, P., Hennekens, C. H., Malinow, M. R., Kok, F. J., Willett, W. C., & Stampfer, M. J. (1994) · Stroke · doi:10.1161/01.str.25.10.1924 · Cited by 379
Folic acid—an innocuous means to reduce plasma homocysteine
Brattström, L. E., Israelsson, B., Jeppsson, J.-O., & Hultberg, B. L. (1988) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365518809167487 · Cited by 363
Self-citationVitamin Requirements for the Treatment of Hyperhomocysteinemia in Humans
Ubbink, J. B., Hayward Vermaak, W., Merwe, A. V. D., Becker, P. J., Delport, R., & Potgieter, H. C. (1994) · The Journal of Nutrition · doi:10.1093/jn/124.10.1927 · Cited by 357
ANDERSSON, A., BRATTSTRÖM, L., ISRAELSSON, B., ISAKSSON, A., HAMFELT, A., & HULTBERG, B. (1992) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1992.tb01940.x · Cited by 317
Self-citationHomocysteine metabolism, hyperhomocysteinaemia and vascular disease: An overview
Castro, R., Rivera, I., Blom, H. J., Jakobs, C., & de Almeida, I. T. (2006) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-006-0106-5 · Cited by 312
Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke.
Coull, B. M., Malinow, M. R., Beamer, N., Sexton, G., Nordt, F., & de Garmo, P. (1990) · Stroke · doi:10.1161/01.str.21.4.572 · Cited by 308
Blood Levels of Homocysteine and Increased Risks of Cardiovascular Disease: Causal or Casual?
Christen, W. G., Ajani, U. A., Glynn, R. J., & Hennekens, C. H. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.4.422 · Cited by 304
Plasma homocyst(e)ine levels in men with premature coronary artery disease
Genest, J. J., McNamara, J. R., Salem, D. N., Wilson, P. W. F., Schaefer, E. J., & Malinow, M. R. (1990) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(90)90542-w · Cited by 296
Biochemical and Clinical Aspects of Methotrexate Neurotoxicity
Vezmar, S., Becker, A., Bode, U., & Jaehde, U. (2003) · Chemotherapy · doi:10.1159/000069773 · Cited by 267
Saposnik, G., Ray, J. G., Sheridan, P., McQueen, M., Lonn, E., & the HOPE 2 Investigators (2009) · Stroke · doi:10.1161/strokeaha.108.529503 · Cited by 260
BRATTSTRÖM, L., LINDGREN, A., ISRAELSSON, B., MALINOW, M. R., NORRVING, B., UPSON, B., & HAMFELT, A. (1992) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1992.tb01829.x · Cited by 257
Hyperhomocyst(e)inemia. A common and easily reversible risk factor for occlusive atherosclerosis.
Malinow, M. R. (1990) · Circulation · doi:10.1161/01.cir.81.6.2004 · Cited by 253
Celermajer, D. S., Sorensen, K., Ryalls, M., Robinson, J., Thomas, O., Leonard, J. V., & Deanfield, J. E. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90203-d · Cited by 252
Metadata
- Authors
- Brattstrom, L. E., Hardebo, J. E., & Hultberg, B. L.
- Venue
- Stroke
- Published
- 1984-11
- Volume
- 15
- Issue
- 6
- Pages
- 1012-1016
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W2123507435
- Cited by
- 282
- References
- 16
- FWCI
- 3.78
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.